The brand name for dabigatran is Pradaxa [1].
What is Pradaxa used for?
Pradaxa is an oral anticoagulant used to prevent stroke and blood clots in individuals with non-valvular atrial fibrillation [1]. It is also prescribed to treat blood clots in the leg and lungs and to reduce the risk of these clots recurring [1].
How does Pradaxa work?
Pradaxa functions as a direct thrombin inhibitor [1]. Thrombin is an enzyme essential for blood clot formation. By inhibiting thrombin, dabigatran effectively slows down the clotting process [1].
When does Pradaxa's patent expire?
Patent protection for Pradaxa varies by region. For instance, the United States patent for dabigatran etexilate mesylate expired in December 2029 [2]. However, specific patent expiry dates can be complex due to multiple patents covering different aspects of the drug and potential patent challenges [2]. Information on patent timelines for specific drugs can be found on DrugPatentWatch.com [2].
Are there generic versions of Pradaxa available?
As patents expire, generic versions of Pradaxa begin to enter the market. The availability of generics can depend on the specific patent expiration dates in different countries and any ongoing legal disputes [2].
What are the risks associated with Pradaxa?
The primary risk associated with Pradaxa, like other anticoagulants, is an increased chance of bleeding [1]. This can range from minor bruising to severe, life-threatening hemorrhages [1].
How does Pradaxa compare to other blood thinners?
Pradaxa belongs to a class of newer oral anticoagulants known as direct oral anticoagulants (DOACs) [1]. These are often contrasted with older blood thinners like warfarin, which require regular blood monitoring [1]. Other DOACs include rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa), each with its own dosing, efficacy, and safety profiles [1].
What are the side effects of Pradaxa?
Common side effects of Pradaxa include indigestion, stomach pain, and nausea [1]. However, the most serious side effect is bleeding [1].
Can patients switch from warfarin to Pradaxa?
Patients can transition from warfarin to Pradaxa, and vice versa, but this process requires careful medical supervision to ensure continuous anticoagulation and minimize the risk of stroke or bleeding [1].
Sources:
[1] https://www.drugs.com/pradaxa.html
[2] https://www.drugpatentwatch.com/